Skip to main content
. 2021 Jun 3;13(11):2791. doi: 10.3390/cancers13112791

Figure 1.

Figure 1

The schematic flow of study design. Patients suspected of PDAC (N = 166) performed endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) to obtain pancreas specimens, which were examined by pathologists after hematoxylin & eosin (H&E) staining. DNAs were extracted from each PDAC specimen, and DNA analytes (N = 116) passing a quality control (QC) test were sequenced by using CancerSCAN® panel. PDAC, pancreatic ductal adenocarcinoma.